Radiesse™ for facial rejuvenation

Cosmetic Dermatology

Volumn 18, Issue 12, 2005, Pages 823-826

  Felderman, Lenora I ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTIVIRUS AGENT; CLOPIDOGREL; CORTICOSTEROID; GINKGO BILOBA EXTRACT; HYDROXYAPATITE; HYPERICUM PERFORATUM EXTRACT; LIDOCAINE; LOCAL ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN; XANTHOPHYLL;

AGING; ANTICOAGULANT THERAPY; CLINICAL PRACTICE; DIET SUPPLEMENTATION; ECCHYMOSIS; EDEMA; FACE; HERPES SIMPLEX; HUMAN; INJECTION SITE; INJECTION SITE PAIN; LIP; LOCAL ANESTHESIA; LONGEVITY; MOUTH; NOSE; PRACTICE GUIDELINE; REJUVENATION; REVIEW; SHELF LIFE; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS INFECTION; VITAMIN INTAKE; WRINKLE;

EID: 33646728623     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Alibhai H. The brave new world of facial dermal fillers. Aesthetic Buyers Guide. 2005:48-52.
2. Comite SL, Liu JF, Balasubramanian S, et al. Treatment of HIV-associated facial lipoatrophy with Radiance FN™ (Radiesse™). Dermatol Online J. 2005;10(2):2. Available at: http://www.dermatology. cdlib.org/102/therapy/HIV/ comite.html. Accessed September 1, 2005.
3. Tzikas TL. Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg. 2004;6:234-239.
4. Hubbard W. Bioform implants: biocompatibility. Franksville, Wise: Bioform Medical Inc; 2003.
5. Jesitus J. Radiesse effective intermediate filler: corrects variety of cosmetic problems, though durability disappoints. Cosmet Surg Times (Special Report). August 2004:14,17.
6. Sklar J, White SM. Radiance FN: a new soft tissue filler. Dermatol Surg. 2004;30:764-768.
7. Busso M. Soft tissue augmentation with Radiance FN™. Aesthetic Trends Technol. 2003;2(3).